Clinical Assessment of Cognitive Decline in Adults with Down Syndrome

被引：21
|
作者：
Sabbagh, Marwan [1 ]
Edgin, Jamie [2 ,3 ]
机构：
[1] Banner Sun Hlth Res Inst, Cleo Roberts Ctr Clin Res, Sun City, AZ 85351 USA
[2] Univ Arizona, Dept Psychol, Tucson, AZ USA
[3] Univ Arizona, Sonoran Univ Ctr Excellence Dev Disabil, Tucson, AZ USA
来源：
CURRENT ALZHEIMER RESEARCH | 2016年 / 13卷 / 01期
关键词：
Alzheimer's disease; assessment; decline; dementia; down syndrome; neuropsychological; sleep; POSITRON-EMISSION-TOMOGRAPHY; OBSTRUCTIVE SLEEP-APNEA; IN-VIVO MRI; ALZHEIMERS-DISEASE; INTELLECTUAL DISABILITY; BEHAVIOR CHANGES; AMYLOID-BETA; TEST BATTERY; DEMENTIA; AGE;
D O I：
10.2174/1567205012666150921095724
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Down syndrome is an intellectual disability requiring periodic monitoring of cognition given the near universal presence of Alzheimer's Disease related neuropathology and high rates of dementia in middle adulthood. We review current approaches to detecting decline in this population, including informant-based measures, dementia screening tools, and neuroimaging techniques. The challenges for detecting decline in this group are discussed, including the need to take into account premorbid cognitive function as well as medical comorbidity.
引用
收藏
页码：30 / 34
页数：5
相关论文
共 50 条
  • [41] Amyloid-β and tau deposition influences cognitive and functional decline in Down syndrome
    Grigorova, Monika
    Mak, Elijah
    Brown, Stephanie S. G.
    Beresford-Webb, Jessica
    Hong, Young T.
    Fryer, Tim D.
    Coles, Jonathan P.
    Aigbirhio, Franklin I.
    Tudorascu, Dana
    Cohen, Annie
    Christian, Bradley T.
    Ances, Beau
    Handen, Benjamin L.
    Laymon, Charles M.
    Klunk, William E.
    Clare, Isabel C. H.
    Holland, Anthony J.
    Zaman, Shahid H.
    NEUROBIOLOGY OF AGING, 2022, 119 : 36 - 45
  • [42] Pain and Cognitive Functioning in Adults with Down Syndrome
    de Knegt, Nanda C.
    Lobbezoo, Frank
    Schuengel, Carlo
    Evenhuis, Heleen M.
    Scherder, Erik J. A.
    PAIN MEDICINE, 2017, 18 (07) : 1264 - 1277
  • [43] VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
    Lleo, Alberto
    Carmona-Iragui, Maria
    Videla, Laura
    Fernandez, Susana
    Benejam, Bessy
    Pegueroles, Jordi
    Barroeta, Isabel
    Altuna, Miren
    Valldeneu, Silvia
    Xiao, Mei-Fang
    Xu, Desheng
    Nunez-Llaves, Raul
    Querol-Vilaseca, Marta
    Sirisi, Sonia
    Bejanin, Alexandre
    Iulita, M. Florencia
    Clarimon, Jordi
    Blesa, Rafael
    Worley, Paul
    Alcolea, Daniel
    Fortea, Juan
    Belbin, Olivia
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [44] The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil
    Fonseca, Luciana M.
    Haddad, Glenda G.
    Mattar, Guilherme P.
    de Oliveira, Melaine C.
    Simon, Sharon S.
    Guilhoto, Laura M.
    Busatto, Geraldo F.
    Zaman, Shahid
    Holland, Anthony J.
    Hoexter, Marcelo Q.
    Bottino, Cassio M.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2019, 41 (03) : 225 - 233
  • [45] Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms
    Anderson-Mooney, Amelia J.
    Schmitt, Frederick A.
    Head, Elizabeth
    Lott, Ira T.
    Heilman, Kenneth M.
    BRAIN AND COGNITION, 2016, 104 : 48 - 57
  • [46] Outcome Measures for Clinical Trials in Down Syndrome
    Esbensen, Anna J.
    Hooper, Stephen R.
    Fidler, Deborah
    Hartley, Sigan L.
    Edgin, Jamie
    d'Ardhuy, Xavier Liogier
    Capone, George
    Conners, Frances A.
    Mervis, Carolyn B.
    Abbeduto, Leonard
    Rafii, Michael
    Krinsky-McHale, Sharon J.
    Urv, Tiina
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2017, 122 (03): : 247 - 281
  • [47] Sleep disturbances and cognitive decline: recommendations on clinical assessment and the management
    Guarnieri, B.
    Cerroni, G.
    Sorbi, S.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2015, 153 (2-3):
  • [48] Down syndrome: Distribution of brain amyloid in mild cognitive impairment
    Keator, David B.
    Phelan, Michael J.
    Taylor, Lisa
    Doran, Eric
    Krinsky-McHale, Sharon
    Price, Julie
    Ballard, Erin E.
    Kreisl, William C.
    Hom, Christy
    Nguyen, Dana
    Pulsifer, Margaret
    Lai, Florence
    Rosas, Diana H.
    Brickman, Adam M.
    Schupf, Nicole
    Yassa, Michael A.
    Silverman, Wayne
    Lott, Ira T.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [49] SCREENING FOR DEMENTIA IN ADULTS WITH DOWN SYNDROME
    Kuwano, R.
    Terada, S.
    Takenoshita, S.
    Inoue, T.
    Chojyu, A.
    Suemitsu, S.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 732 - 732
  • [50] Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome
    Ptomey, Lauren T.
    Szabo, Amanda N.
    Willis, Erik A.
    Gorczyca, Anna M.
    Greene, J. Leon
    Danon, Jessica C.
    Donnelly, Joseph E.
    DISABILITY AND HEALTH JOURNAL, 2018, 11 (03) : 486 - 490
12345